Results 41 to 50 of about 11,975,902 (386)

Manipulated Oral and Rectal Drugs in a Paediatric Swedish University Hospital, a Registry-Based Study Comparing Two Study-Years, Ten Years Apart

Pharmaceuticals, 2022
This is a registry-based study with the aim of describing and comparing the frequency of manipulations of solid oral and rectal medicines in 2009 and 2019 at inpatient units and an emergency department in a paediatric hospital within a Swedish university
Åsa C. Andersson, Staffan Eksborg, Ulrika Förberg, Per Nydert, Synnöve Lindemalm   +4 more
doaj   +1 more source

Chipping away at gamma-H2AX foci [PDF]

, 2009
The mammalian histone H2AX protein functions as a dosage-dependent genomic caretaker and tumor suppressor. Phosphorylation of H2AX to form gamma-H2AX in chromatin around DNA double strand breaks (DSBs) is an early event following induction of these ...
Bassing, Craig H, Orange, Jordan S, Sanborn, Keri B, Savic, Velibor   +3 more
core   +1 more source

A REVIEW ON CIPROFLOXACIN: DOSAGE FORM PERSPECTIVE

International Journal of Applied Pharmaceutics, 2018
Ciprofloxacin (CF) is one of the topmost selling antibiotics and it is available at a cheap cost which is used to treat many bacterial infections. Many research scientists are working on this drug for various applications on different drug delivery ...
M. Vidyavathi, G. Srividya
semanticscholar   +1 more source

Assessing subvisible particle risks in monoclonal antibodies: insights from quartz crystal microbalance with dissipation, machine learning, and in silico analysis

mAbs
Throughout the lifecycle of biopharmaceutical development and manufacturing, monoclonal antibodies (mAbs) are subjected to diverse interfacial stresses and encounter various container surfaces.
Yibo Wang, Alexis Hanford, Mehdi Boroumand, Cavan Kalonia, Jesse Leissa, Mitali Shah, Tony Pham, Theodore Randolph, Indira Prajapati   +8 more
doaj   +1 more source

Selective Sensing of Darolutamide and Thalidomide in Pharmaceutical Preparations and in Spiked Biofluids

Biosensors, 2022
Selective spectrofluorometric sensing is introduced for the analysis of non-steroidal anti-androgens, darolutamide, and thalidomide in pharmaceutical preparations and biofluids.
Wael Talaat, Abdelbasset A. Farahat, Reda Mohammed Keshk   +2 more
doaj   +1 more source

Nanogels for pharmaceutical and biomedical applications and their fabrication using 3D printing technologies [PDF]

, 2018
Nanogels are hydrogels formed by connecting nanoscopic micelles dispersed in an aqueous medium, which give an opportunity for incorporating hydrophilic payloads to the exterior of the micellar networks and hydrophobic payloads in the core of the micelles.
Cho, Hyunah, Jammalamadaka, Udayabhanu, Tappa, Karthik   +2 more
core   +3 more sources

Drug Transport System Based on Phospholipid Nanoparticles: Production Technology and Characteristics

Pharmaceutics, 2022
One of the current trends in modern pharmaceuticals is the supply of drugs by transport systems. The use of delivery systems allows to increase the therapeutic efficacy, tolerability, and safety of drug therapy.
Elena G. Tikhonova, Maxim A. Sanzhakov, Yulia A. Tereshkina, Lyubov V. Kostryukova, Yulia Yu. Khudoklinova, Nadezhda A. Orlova, Daria V. Bobrova, Olga M. Ipatova   +7 more
doaj   +1 more source

Clinical Translation of Long-Acting Drug Delivery Systems for Posterior Capsule Opacification Prophylaxis

Pharmaceutics, 2023
Posterior capsule opacification (PCO) remains the most common cause of vision loss post cataract surgery. The clinical management of PCO formation is limited to either physical impedance of residual lens epithelial cells (LECs) by implantation of ...
Xinyang Li, Chen Liang, Yexuan Guo, Jing Su, Xi Chen, Robert B. Macgregor, Rui Xue Zhang, Hong Yan   +7 more
doaj   +1 more source

Selection Of A Filler For Tablets Manufactured With Direct Compression Method Containing Dry Ginger Extract [PDF]

, 2019
The preliminary studies of physico-chemical and pharmaco-technological properties of the dry extract of ginger have determined the need for introduction of different groups of excipients for developing a solid dosage form for the treatment of type II ...
Alkhalaf, M. (Malek), Gerbina, N. (Nataliia), Ruban, О. (Оlena)   +2 more
core   +3 more sources

Biophysical analysis of angiotensin II and amyloid‐β cross‐interaction in aggregation and membrane disruption

FEBS Letters, EarlyView.
Angiotensin II (AngII), a neuropeptide, interacts with amyloid‐β (Aβ), a key player in Alzheimer's disease. This study reveals that AngII reduces Aβ aggregation and membrane disruption in vitro. Biophysical assays and molecular modeling suggest AngII binds disordered Aβ forms, potentially modulating early amyloidogenic events and contributing to ...
Mohsen Habibnia, Eric Catalina‐Hernandez, Maialen Cabrerizo‐Idiazabal, Ramon Barnadas‐Rodríguez, Mario Lopez‐Martin, Alex Peralvarez‐Marin   +5 more
wiley   +1 more source